The TGA has published the
outcome of a decision relating to
the promotion of a product called
Macutec by Stiltec Pty Ltd.
In Aug the TGA delegate of the
Secretary made an order about ads
on the macutec.com.au website
which found that it breached the
Therapeutic Goods Advertising
Code, carrying incorrect
and unbalanced claims and
inappropriately referred to serious
medical conditions.
Stiltec was ordered to withdraw
representations that Macutec
protects against macular damage as
well as publish a retraction.
The company has worked
closely with the TGA to ensure full
compliance with the orders, with
the website “considered to be
compliant with the order including
the publication of the retraction” as
at 26 Sep 2013.The above article was sent to subscribers in Pharmacy Daily's issue from 07 Nov 13 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 07 Nov 13
MONTU Group, its subsidiary Alternaleaf Pty Ltd, and their common director Christopher Strauch are facing legal action by the Therapeutic Goods Administration (TGA) in the Federal Court of Australia for alleged unlawful advertising on the effectiveness of their medicinal cannabis products.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.